does retatrutide cause low libido and Libido: Sexual Health Guide (2026) RETATRUTIDE: A Medication for Diabetes

In April 2026 Health Canada published an advisory (RA-81874) reminding the public that peptides of this type are generally regulated as prescription drugs, and that research use only labelling does not by itself change a products regulatory status

doi: 10.1111/liv.16150, 6

Eligible patients may ask about the Medicare GLP-1 Bridge Program

These range from manufacturer-sponsored savings cards to income-based patient assistance programs that provide medications at no cost

Transparency is the whole game in a market with no retail pharmacy oversight

This change would abruptly disrupt care for patients who are benefiting from GLP-1s